YOURITY

Serial Number 98939754
688

Registration Progress

Application Filed
Jan 6, 2025
Under Examination
May 6, 2025
Approved for Publication
Mar 11, 2025
Published for Opposition
Mar 11, 2025
Registered

Basic Information

Serial Number
98939754
Deadline
November 6, 2025
Description
Statement of Use or 1st Extension Due
Filing Date
January 6, 2025
Published for Opposition
March 11, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
May 6, 2025
Application
Pending
Classes
005

Rights Holder

Eli Lilly and Company

03
Address
Lilly Corporate Center
Indianapolis, IN 46285

Ownership History

Eli Lilly and Company

Original Applicant
03
Indianapolis, IN

Eli Lilly and Company

Original Applicant
03
Indianapolis, IN

Eli Lilly and Company

Owner at Publication
03
Indianapolis, IN

Eli Lilly and Company

Owner at Publication
03
Indianapolis, IN

Legal Representation

Attorney
Bruce W. Longbottom

Application History

16 events
Date Code Type Description
May 6, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 6, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 11, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 11, 2025 PUBO A PUBLISHED FOR OPPOSITION
Mar 11, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 11, 2025 PUBO A PUBLISHED FOR OPPOSITION
Mar 5, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 5, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 12, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 12, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 5, 2025 DOCK D ASSIGNED TO EXAMINER
Feb 5, 2025 DOCK D ASSIGNED TO EXAMINER
Jan 6, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 6, 2025 NWAP I NEW APPLICATION ENTERED
Jan 6, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 6, 2025 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Classification

International Classes
005